CALL FOR PAPERS

Author Information

CERTIFICATE

IMPACT FACTOR 2021

Subject Area

Life Sciences / Biology
Architecture / Building Management
Asian Studies
Business & Management
Chemistry
Computer Science
Economics & Finance
Engineering / Acoustics
Environmental Science
Agricultural Sciences
Pharmaceutical Sciences
General Sciences
Materials Science
Mathematics
Medicine
Nanotechnology & Nanoscience
Nonlinear Science
Chaos & Dynamical Systems
Physics
Social Sciences & Humanities

Why Us? >>

Open Access
Peer Reviewed
Rapid Publication
Life time hosting
Free promotion service
Free indexing service
More citations
Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

Impact of pharmaceutical care and assessment of qol of cabg and ptca patients with co-morbid conditions

Author:

Nithiya Regi Kuriakose, Dr. Shafeeq Mattummal, Merin Suresh, Jisha Sara John, Anil Babu, A., Prof. R. Raju and Santhra Vincent

Subject Area:

Health Sciences

Abstract:

Background: The aim of this study is to assess the quality of life of CABG and PTCA patients with co morbid condition . Methods: This study was a prospective, well-controlled, interventional study conducted in 120 patients over a period of 6 months in a tertiary care teaching hospital. Patient quality of life were assessed using MacNew Heart related QoL questionnaire. Results: In this study, commonly seen co-morbid condition is Type 2 DM (65%) and least condition is Epilepsy (3.3%). Some of the risk factors identified among patients were Type 2 DM, Hypertension, Dyslipidemia, Family History, Social habits and Obesity. The study showed significant improvement in quality of life (P <0.01). Conclusion: The present study was performed to get a comprehensive overview of the impact of pharmacist in improving the QOL of CABG and PTCA patients and managing the co-morbid condition hence reduces the chances of re-occlusion.

PDF file: